91 related articles for article (PubMed ID: 27427383)
1. Computational analysis and enzyme assay of inhibitor response to disease single nucleotide polymorphisms (SNPs) in lipoprotein lipase.
He D; Huang L; Xu Y; Pan X; Liu L
J Bioinform Comput Biol; 2016 Oct; 14(5):1650028. PubMed ID: 27427383
[TBL] [Abstract][Full Text] [Related]
2. Orlistat response to missense mutations in lipoprotein lipase.
Chen H; Jia J; Ni Z; Vastermark A; Wu B; Le Y; Jawad U
Biotechnol Appl Biochem; 2017 Jul; 64(4):464-470. PubMed ID: 27097985
[TBL] [Abstract][Full Text] [Related]
3. Interactions of lipoprotein lipase with the active-site inhibitor tetrahydrolipstatin (Orlistat).
Lookene A; Skottova N; Olivecrona G
Eur J Biochem; 1994 Jun; 222(2):395-403. PubMed ID: 8020477
[TBL] [Abstract][Full Text] [Related]
4. Lipoprotein abnormalities in compound heterozygous lipoprotein lipase deficiency after treatment with a low-fat diet and orlistat.
Blackett P; Tryggestad J; Krishnan S; Li S; Xu W; Alaupovic P; Quiroga C; Copeland K
J Clin Lipidol; 2013; 7(2):132-9. PubMed ID: 23415432
[TBL] [Abstract][Full Text] [Related]
5. Lipoprotein lipase: from gene to obesity.
Wang H; Eckel RH
Am J Physiol Endocrinol Metab; 2009 Aug; 297(2):E271-88. PubMed ID: 19318514
[TBL] [Abstract][Full Text] [Related]
6. Very-low-density lipoprotein-induced triglyceride accumulation in human mesangial cells is mainly mediated by lipoprotein lipase.
Li J; Li H; Wen YB; Li XW
Nephron Physiol; 2008; 110(1):p1-10. PubMed ID: 18698144
[TBL] [Abstract][Full Text] [Related]
7. Ex vivo measurement of lipoprotein lipase-dependent very low density lipoprotein (VLDL)-triglyceride hydrolysis in human VLDL: an alternative to the postheparin assay of lipoprotein lipase activity?
Pruneta V; Autran D; Ponsin G; Marcais C; Duvillard L; Verges B; Berthezene F; Moulin P
J Clin Endocrinol Metab; 2001 Feb; 86(2):797-803. PubMed ID: 11158049
[TBL] [Abstract][Full Text] [Related]
8. Association of lipoprotein lipase (LPL) single nucleotide polymorphisms with type 2 diabetes mellitus.
Cho YS; Go MJ; Han HR; Cha SH; Kim HT; Min H; Shin HD; Park C; Han BG; Cho NH; Shin C; Kimm K; Oh B
Exp Mol Med; 2008 Oct; 40(5):523-32. PubMed ID: 18985010
[TBL] [Abstract][Full Text] [Related]
9. Relationship of lipoprotein lipase gene variants and fasting triglyceride levels in a pediatric population: The CASPIAN-III study.
Kelishadi R; Hashemipour M; Esteki B; Tajadini MH; Rafiei L; Motlagh ME; Vaseghi G; Ardalan G; Javanmard SH
Adv Clin Exp Med; 2017; 26(1):77-82. PubMed ID: 28397436
[TBL] [Abstract][Full Text] [Related]
10. Lipoprotein lipase: A bioinformatics criterion for assessment of mutations as a risk factor for cardiovascular disease.
Glisic S; Arrigo P; Alavantic D; Perovic V; Prljic J; Veljkovic N
Proteins; 2008 Feb; 70(3):855-62. PubMed ID: 17803213
[TBL] [Abstract][Full Text] [Related]
11. Estimation of plasma triglycerides with correction for free glycerol by orlistat inhibition of lipoprotein lipase activity.
Nagaraju R; Joshi AK; Rajini PS
Anal Biochem; 2013 Aug; 439(1):44-6. PubMed ID: 23597845
[TBL] [Abstract][Full Text] [Related]
12. Lipoprotein lipase: structure, function, regulation, and role in disease.
Mead JR; Irvine SA; Ramji DP
J Mol Med (Berl); 2002 Dec; 80(12):753-69. PubMed ID: 12483461
[TBL] [Abstract][Full Text] [Related]
13. Newly identified missense mutation reduces lipoprotein lipase activity in Taiwanese patients with hypertriglyceridemia.
Kao JT; Hsiao WH; Yu CJ; Chiang FT
J Formos Med Assoc; 1999 Sep; 98(9):606-12. PubMed ID: 10560236
[TBL] [Abstract][Full Text] [Related]
14. [Current progress in lipoprotein lipase and atherosclerosis].
Tian GP; Chen WJ; He PP; Yin WD; Tnag CK
Sheng Li Ke Xue Jin Zhan; 2012 Oct; 43(5):345-50. PubMed ID: 23316606
[TBL] [Abstract][Full Text] [Related]
15. Kojic acid repurposing as a pancreatic lipase inhibitor and the optimization of its production from a local Aspergillus oryzae soil isolate.
El-Korany SM; Helmy OM; El-Halawany AM; Ragab YE; Zedan HH
BMC Biotechnol; 2020 Oct; 20(1):52. PubMed ID: 33008398
[TBL] [Abstract][Full Text] [Related]
16. Lipoprotein lipase: structure, function and mechanism of action.
Santamarina-Fojo S; Brewer HB
Int J Clin Lab Res; 1994; 24(3):143-7. PubMed ID: 7819594
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of lipoprotein lipase activity by tetrahydrolipstatin.
Lobo LI; Wilton DC
Biochem Soc Trans; 1997 Nov; 25(4):S682. PubMed ID: 9450109
[No Abstract] [Full Text] [Related]
18. Short communication: Identification of two polymorphisms in the goat lipoprotein lipase gene and their association with milk production traits.
Badaoui B; Serradilla JM; Tomàs A; Urrutia B; Ares JL; Carrizosa J; Sànchez A; Jordana J; Amills M
J Dairy Sci; 2007 Jun; 90(6):3012-7. PubMed ID: 17517743
[TBL] [Abstract][Full Text] [Related]
19. Calorimetric approach for comparison of Angiopoietin-like protein 4 with other pancreatic lipase inhibitors.
Villo L; Risti R; Reimund M; Kukk K; Samel N; Lookene A
Biochim Biophys Acta Mol Cell Biol Lipids; 2020 Feb; 1865(2):158553. PubMed ID: 31676442
[TBL] [Abstract][Full Text] [Related]
20. Association of the lipoprotein lipase gene T+495G polymorphism with central obesity and serum lipids in a twin study.
Li J; Huang A; Hu Y; Chen D
Ann Epidemiol; 2008 Oct; 18(10):760-7. PubMed ID: 18693040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
